Veradermics (MANE) P/S ratio

There is no P/S ratio history on record here for Veradermics (MANE). Figures as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/S ratio needs at least 3 fiscal years; none is on record here for Veradermics. Nothing is estimated to fill the gap.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Veradermics and comparable companies
CompanyP/S ratio
Teleflex TFX3.2×
Mirum Pharmaceuticals MIRM11.5×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on MANE

Veradermics, figure by figure

Veradermics (MANE) overview: price, valuation and scorecardAll health care companies by market value

Veradermics P/S ratio: questions and answers

How is Veradermics's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Veradermics (MANE) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/MANE/ps-ratio

Underlying data: Yahoo Finance.